Skip to content

Virtual Reality for Power Wheelchair Training

Assessing the Effectiveness of Virtual Reality for Power Wheelchair Driving Training

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03562455
Enrollment
12
Registered
2018-06-19
Start date
2018-06-19
Completion date
2019-08-02
Last updated
2022-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Diseases

Keywords

Virtual Reality, Wheelchairs

Brief summary

The objective of this study is to evaluate the impact of VRSim 3.0 on power wheelchair (PWC) driving skills and to obtain qualitative feedback from users on the design of the virtual reality (VR) simulator to inform device development.

Detailed description

A virtual reality platform may lead to better training of people with complex disabilities who desire to be power wheelchair users and thus allow them to benefit from living a more active life. A virtual reality training program could significantly impact the lives of people with disabilities by improving function, reducing abandonment of power wheelchairs, and reducing morbidity and mortality and associated costs occurring from power wheelchair accidents. This new virtual reality training program will reflect improvements in accessibility, customization, simulator sickness, ease of use, and will have report generating capabilities as compared to previous virtual reality training platforms. The investigators expect that virtual reality training will be a superior alternative to standard in-person wheelchair training.

Interventions

OTHERVRSim 3.0

VRSim 3.0 is a virtual reality training module.

BEHAVIORALIn-Person Wheelchair Training

A therapist will be used to train power wheelchair users.

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Masking description

The individual assessing performance outcomes will not be aware of which intervention the participants received.

Intervention model description

The study will contain two arms. One group will receive virtual reality power wheelchair training, and the other will receive in-person wheelchair training by a therapist.

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Volunteers must be 14 years or older. * Volunteers must have a disability that prevents them from effectively and independently using a manual wheelchair, power assist wheelchair, or scooter. * Volunteers must be able to communicate in English, follow simple commands, and give written informed consent.

Exclusion criteria

* Volunteers with active seizures. * Volunteers who have active pelvic or thigh wounds. * Volunteers who require a test wheelchair but who exceed the weight capacity of the test wheelchair (\>300 lbs). * Volunteers who require a test wheelchair but also require specialized seating that cannot be replicated for the training.

Design outcomes

Primary

MeasureTime frameDescription
Power Wheelchair Driving SkillThis outcome measure will be assessed at each of 4 training sessions, which may take up to one year to complete.Power wheelchair driving skills will be evaluated using the Power Mobility Clinical Driving Assessment (PMCDA). The PMCDA contains 23 questions related to specific power wheelchair driving tasks. Each task will be given a score from 1 to 3; a score of 1 will be given if the driver requires physical assistance or cannot complete the task, a score of 2 will be given if the driver requires verbal or auditory hints or cues, but no physical assistance, and a score of 3 will be given if the driver completes the task without help. Scores will be added together for a possible total from 23 to 69.

Secondary

MeasureTime frameDescription
Perception of Virtual Reality Training SystemThis outcome measure will be assessed at the completion of the study, which may take up to one year to complete.Qualitative feedback on the participants' experience with VRSim 3.0 will be obtained to inform future software development using a semi-structured interview as well as a Virtual Experience Test (VET) survey. The semi-structured interview will contain open-ended questions aimed at exploring usability factors that may be barriers or facilitators to the use of VR for PWC driving training. The VET is a validated survey instrument that will be used to measure the virtual environment experience. It will contain 17 questions based on based upon five dimensions of experiential design: sensory, cognitive, affective, active, and relational. The survey questions will be scored from 1 (strongly disagree) to 5 (strongly agree).
Simulator SicknessThis outcome measure will be assessed at the beginning and end of 4 training sessions, which may take up to one year to complete.Participants in the virtual reality group will be given a Simulator Sickness Questionnaire (SSQ) at the beginning and end of each training session to assess the degree of simulator sickness induced by the gaming platform. The SSQ contains 16 questions based on symptoms of simulator sickness, and participants will rate each symptom as either none, slight, moderate, or severe.
Perceived Workload of TrainingThis outcome measure will be assessed at each of 4 training sessions, which may take up to one year to complete.Participants will be given a NASA-Task Load Index (NASA-TLX) survey to assess perceived workload at the end of each training session. The NASA-TLX contains 6 questions to assess workload on a scale from low to high.
Power Wheelchair Driving CapacityThis outcome measure will be measured at the beginning and end of the study, which may take up to one year to complete.Participants will be evaluated using the Power Mobility Screening Tool (PMST) to assess driving capacity. The PMST contains 5 questions based on motor, sensory, and cognitive skills. The questions will be scored from 1 to 3, and will be added together for a possible total from 5 to 15.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026